NCR3LG1 and melanoma: More importantly, NK cells may be effective effector cells in the treatment of melanomas because of the low surface levels of HLA class I molecules on melanoma cells and the fact that these cells frequently produce ligands (such as B7H6, MICA/B, ULBPs, PVR, and nectin2) recognized by key activating NK receptors (22).